|
Jean-Charles Soria is a full professor of Medicine and Medical Oncology
at the Paris University XI. He is a tenure-track and fulltime cancer specialist
at the Institute Gustave Roussy. Prof. Soria trained as a medical oncologist
and obtained a silver medal from the Paris
Medical School
in 1997. He gained a PhD degree in the Fundamental Basis of Oncogenesis in
2001, and completed his training with a two-year post-doctoral fellowship in
the Department of Thoracic Head and Neck Medical Oncology at MD Anderson Cancer
Center, Houston, USA.
Prof.
Soria is currently head of the phase I program at the Institute Gustave Roussy
and a member of the lung cancer unit with a focus on targeted therapies. His
main research interests are: early clinical development, phase I trials across
solid tumors, pharmacodynamic biomarkers, early phase II trials and lung
cancer. He is also involved in translational research aspects related to tumor
progression, notably in lung cancer models.
Prof.
Soria has led, as principal investigator, 10 phase I trials during the last
three years as well as half a dozen phase II trials in lung cancer. He is
currently the Medical Chair of the French Scientific National Program on lung
cancer (PNES), launched by the French NCI.
Prof.
Soria is member of the Eruopean Society for Medical Oncology (ESMO) since 1997.
He also founded the Flims Alumni Club (FAC) in 2001, and is the Vice-Chair of
ESMO Young Oncologist (YO) Committee since 2007, as well as an ASCO committee
member. He has contributed to over 100 peer-reviewed publications, including
publications as first or last author in the New England Journal of Medicine,
the Journal of the National Cancer Institute, Cancer Research and Clinical
Cancer Research.
| 
